Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoporosis in men].

Maurice Audran1, Erick Legrand, Daniel Chappard

  • 1Service de rhumatologie, CHU & faculté de médecine Angers, 49933 Angers Cedex 9. MaAudran@chu-angers.fr

La Revue Du Praticien
|February 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeated unilateral injections of botulinum toxin in masticatory muscles in adult rats do not amplify condylar and alveolar bone loss nor modify the volume of the hypertrophic bone proliferation at enthesis.

Journal of stomatology, oral and maxillofacial surgery·2024
Same author

Differences in bone microarchitecture between genetic and secondary iron-overload mouse models suggest a role for hepcidin deficiency in iron-related osteoporosis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2023
Same author

Development of a First-in-Class Unimolecular Dual GIP/GLP-2 Analogue, GL-0001, for the Treatment of Bone Fragility.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2023
Same author

(-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice.

Chemico-biological interactions·2022
Same author

ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?

Experimental dermatology·2022
Same author

[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures.

Frontiers in endocrinology·2021
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Osteoporosis in men, though less common than in women, often results from contributing factors like hypogonadism and corticosteroid use. Treatments include testosterone for hypogonadal men and diphosphonates to prevent bone loss and fractures.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Gerontology

Context:

  • Osteoporosis is less prevalent in men than women.
  • Male osteoporosis can be idiopathic or multifactorial.
  • Contributing factors include hypogonadism, corticosteroid therapy, alcohol abuse, and GI/hepatic disorders.

Purpose:

  • To outline the causes and management of male osteoporosis.
  • To highlight the role of specific treatments in preventing bone loss and fractures.

Summary:

  • While male osteoporosis is less common, approximately 60% of cases involve multiple contributing factors to bone loss and fractures.
  • Key secondary causes include hypogonadism, corticosteroid use, alcohol abuse, and gastrointestinal or hepatic conditions.
  • Testosterone therapy is indicated for hypogonadal men, while diphosphonates are effective in managing both primary and secondary male osteoporosis, reducing bone loss and fracture incidence.

Related Experiment Videos

Impact:

  • Provides a concise overview of male osteoporosis etiology and treatment.
  • Informs clinicians on therapeutic options for male osteoporosis.
  • Aids in understanding the multifactorial nature of bone loss in men.